Abstract
No public abstract is available from the verified source records.
Tianshuo Yang, Yaxin Liu, Haoyu Shi, Suli Dai
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2021
The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020
10.1053/j.gastro.2022.05.054 · 2022
Epidemiology of esophageal squamous cell carcinoma
10.1053/j.gastro.2017.08.023 · 2018
Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma
10.1056/nejmoa2111380 · 2022
Effect of Camrelizumab vs placebo added to chemotherapy on survival and progression-free survival in patients with advanced or metastatic esophageal squamous cell carcinoma: the ESCORT-1st randomized clinical trial
10.1001/jama.2021.12836 · 2021
Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis
10.1038/s41467-021-25539-x · 2021
Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment
10.1038/s41467-021-27599-5 · 2021
YY2 serves as a novel prognostic biomarker correlated with immune microenvironment and glycolysis in esophageal carcinoma
10.2174/0113892029358348250124064940 · 2025
The success and the challenge of all-trans retinoic acid in the treatment of cancer
10.1080/10408398.2018.1509201 · 2019
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
10.1038/s41392-021-00670-9 · 2021
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients
10.1158/0008-5472.can-06-1690 · 2006
Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
10.1016/j.intimp.2018.08.007 · 2018
Tumor-derived retinoic acid regulates intratumoral monocyte differentiation to promote immune suppression
10.1016/j.cell.2020.02.042 · 2020
All-trans retinoic acid promotes a tumor suppressive OTUD6B-beta-TrCP-SNAIL axis in esophageal squamous cell carcinoma and enhances immunotherapy
2023
The multifaceted roles of the invariant chain CD74--more than just a chaperone
10.1016/j.bbamcr.2016.03.026 · 2016
Neutrophil profiling illuminates anti-tumor antigen-presenting potency
10.1016/j.cell.2024.02.005 · 2024
Emt
10.1016/j.cell.2016.06.028 · 2016
Inference and analysis of cell-cell communication using CellChat
10.1038/s41467-021-21246-9 · 2021
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
10.1016/j.ccell.2023.02.014 · 2023
CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer
10.1158/1078-0432.ccr-07-0842 · 2007
Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance
10.1038/s41698-024-00522-z · 2024
SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration
10.1038/s41416-024-02683-x · 2024
Tumour-associated neutrophils in patients with cancer
10.1038/s41571-019-0222-4 · 2019
Association of immunosuppressive CD45(+)CD33(+)CD14(−) CD10(−)HLA-DR(−/low) neutrophils with poor prognosis in patients with lymphoma and their expansion and activation through STAT3/arginase-1 pathway in vitro
10.25259/cytojournal_165_2024 · 2024
Single-cell transcriptomic analysis reveals the landscape of epithelial-mesenchymal transition molecular heterogeneity in esophageal squamous cell carcinoma
10.1016/j.canlet.2024.216723 · 2024
Update on epithelial-mesenchymal plasticity in cancer progression
10.1146/annurev-pathmechdis-051222-122423 · 2024
Ubiquitination and deubiquitination in the regulation of epithelial-mesenchymal transition in cancer: shifting gears at the molecular level
10.1016/j.bbamcr.2022.119261 · 2022
Targeting MDSC differentiation using ATRA: A Phase I/II clinical trial combining pembrolizumab and all-trans retinoic acid for metastatic melanoma
10.1158/1078-0432.ccr-22-2495 · 2023
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
10.1016/s1470-2045(23)00108-0 · 2023
All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer
10.1016/j.jhep.2013.07.009 · 2013
Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells
10.1158/0008-5472.can-07-2593 · 2007
A new mouse esophageal cancer cell line (mEC25)-derived pre-clinical syngeneic tumor model for immunotherapy
10.1002/cac2.12066 · 2020
No additional external references are available.